Back to mobile site

Ladenburg Thalmann Downgrades AMAG Pharmaceuticals (AMAG) to Neutral

January 22, 2014 9:46 AM EST Send to a Friend
Ladenburg Thalmann downgraded AMAG Pharmaceuticals (NASDAQ: AMAG) from Buy to Neutral and ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login